Li Li, Ph.D.
Vice President, Operation, Co-founder

Dr. Li has more than 20 years of industry experience in business development and project management in the biotech field. Prior to co-founding AceLink Therapeutics, Dr. Li was a Senior Director of Business Development at Crown Bioscience, a leading translational technology platform company. She was one of the top business executives serving many biotech and pharmaceutical companies for almost 6 years. Before Crown Bioscience, Dr. Li was a Director of Custom Service at Epitomics, a rabbit monoclonal antibody company, later-on acquired by Abcam. At Epitomics, Dr. Li was responsible for the lab operation, project management and account management. Prior to that, Dr. Li also held different scientist positions at Applied Biomics – a proteomics research and service company and at Curagen – a genomics-based target discovery company. Dr. Li received her B.S. in Microbiology from Fudan University, M.S. in Microbiology from Beijing Agriculture University and Ph.D. in Microbiology and Molecular Medicine from Oklahoma State University.

© Copyright AceLink Therapeutics. All rights reserved